Drugs / Midazolam oral solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03276858 | Sep 2017 → Apr 2018 | — | Crinetics Pharmaceuticals Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Midazolam oral solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03276858 ↗ |
| Route | Oral | “On Day 1, 8 subjects will receive a single oral 2 mg dose of midazolam.” NCT03276858 ↗ |